The vendor opportunity at Complete Mobile Drug Testing
Complete Mobile Drug Testing presents a minimal addressable market for software vendors. The 2026 Franchise Disclosure Document reports a single company-owned unit, with no franchised locations currently operating. For a SaaS vendor, this means the total unit count you can sell into is exactly one. The system is headquartered in Wisconsin and operates in the health services sector, providing mobile drug testing services. There is no disclosed average unit volume (AUV) and no year-over-year unit growth rate available, which is consistent with a very early-stage or nascent franchise system. The royalty rate is set at 10% of gross revenue, and the initial franchise agreement term runs for 10 years.
Who controls software purchasing
In a system with only one corporate location and no franchisees, the software buying center is entirely centralized. Purchasing authority rests with the leadership team at the Wisconsin headquarters. No specific executive names or titles are on file in the FranCloud database, but vendors should direct all outreach to the corporate office. There is no multi-unit operator (MUO) layer, no franchisee advisory council, and no distributed decision-making to navigate. This simplifies the sales process considerably: you are selling to a single entity with a single decision-making chain.
Mandated and current tech stack
The only technology mandate extracted from the 2026 FDD is Intuit QuickBooks. This accounting platform is required for franchisees, though with no franchisees currently in the system, the mandate primarily reflects the standard the franchisor intends to enforce as the network grows. No point-of-sale system, customer relationship management tool, scheduling platform, or industry-specific operational software is identified in the available FDD data. For vendors selling complementary or replacement financial software, QuickBooks represents both the incumbent and the mandated standard you would need to displace or integrate with.
Procurement, renewals, and timing
Procurement signals from Item 8 of the FDD are not available in the current extract, so the formal purchasing model—whether designated supplier, approved supplier, or open—remains unknown. The franchise agreement includes renewal provisions allowing for up to two additional five-year terms, but these apply to franchisees, of which there are currently none. With only a corporate unit in operation, there are no franchisee-driven renewal cycles that would create predictable software evaluation windows. Vendors should treat this as an opportunistic, single-account sale rather than a recurring, cycle-driven market.
How to read the Complete Mobile Drug Testing FDD
The 2026 FDD is embedded below for your review. Key sections for software vendors include Item 8 (restrictions on sources of products and services), Item 11 (franchisor's obligations and required technology), and Item 17 (renewal, termination, and transfer). Given the system's size, the FDD will be relatively straightforward, but pay close attention to any technology requirements that may be triggered upon the sale of additional franchises. The document was filed with state franchise regulators and represents the most current legal disclosure available. For a ranked target list of franchise systems with stronger growth signals and larger addressable unit counts, FranCloud can help you prioritize your outreach.